Lantern Pharma Inc.

NASDAQ: LTRN · Real-Time Price · USD
4.61
0.04 (0.88%)
At close: Aug 15, 2025, 3:59 PM
4.66
1.08%
After-hours: Aug 15, 2025, 04:32 PM EDT

Lantern Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
190.49K 174.84K 154.68K 97.42K
Gross Profit
-190.49K -174.84K -154.68K -97.42K
Operating Income
-22.22M -17.88M -14.43M -12.59M
Interest Income
742.36K 765.39K 204.35K 67.93K
Pretax Income
-20.78M -15.96M -14.26M -12.36M
Net Income
-20.78B -15.96M -14.26M -12.36M
Selling & General & Admin
6.09M 5.98M 5.83M 5.02M
Research & Development
16.13M 11.89M 8.6M 7.57M
Other Expenses
-190.49K -174.84K n/a n/a
Operating Expenses
22.03M 17.7M 14.43M 12.59M
Interest Expense
n/a n/a 204.35K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-22.22M 17.88M 14.43M 12.59M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
10.76M 10.84M 10.85M 10.9M
Shares Outstanding (Diluted)
10.76M 10.84M 10.85M 10.9M
EPS (Basic)
-1.93K -1.47 -1.31 -1.13
EPS (Diluted)
-1.93K -1.47 -1.31 -1.13
EBITDA
-20.59M -15.79M -14.42M -12.27M
EBIT
-20.78M -15.96M -14.43M -12.36M
Depreciation & Amortization
190.49K 174.84K 10.08K 97.42K